Current status and prospects for interferon.
D000818:Animals; D000831:Animals, Newborn; D000961:Antilymphocyte Serum / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology; D002462:Cell Membrane / Q000378:metabolism; D000242:Cyclic AMP / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D007369:Interferon Inducers / Q000494:pharmacology*; D007372:Interferons / Q000096:biosynthesis; D007962:Leukocytes / Q000378:metabolism; D051379:Mice; D008954:Models, Biological; D009174:Mycoplasma; D009975:Orthomyxoviridae; D011070:Poly I-C / Q000494:pharmacology; D013268:Stimulation, Chemical
D000961:Antilymphocyte Serum; D000998:Antiviral Agents; D007369:Interferon Inducers; D003609:Dactinomycin; D007372:Interferons; D003513:Cycloheximide; D000242:Cyclic AMP; D011070:Poly I-C